Diaphorina citri psyllid: psy12228


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------26
MPGQSRTQHLFQVQLSAHTWSSSWKAFPLPSDLSTAAVLLPNLFWAFNIATSVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGNDAVRFIGFDLCILVFFHDSTLLKTTSTIASLILRNQKVSVLLDLIFVF
ccccccccEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccEEEEEEEccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEECcccCEEEEECcccccHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHccccHHHccccccccccEEEECccccEEEccccccEEEccccccccccccccc
*********LFQVQLSAHTWSSSWKAFPLPSDLSTAAVLLPNLFWAFNIATSVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH***************NGNVLTEKDLISFAYQVANGMHYLQSRKVGNDAVRFIGFDLCILVFFHDSTLLKTTSTIASLILRNQKVSVLLDLIFVF
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MPGQSRTQHLFQVQLSAHTWSSSWKAFPLPSDLSTAAVLLPNLFWAFNIATSVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGNDAVRFIGFDLCILVFFHDSTLLKTTSTIASLILRNQKVSVLLDLIFVF

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Fibroblast growth factor receptor 4 Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4.confidentQ498D6
Fibroblast growth factor receptor 1 Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.confidentP16092
Fibroblast growth factor receptor Receptor for basic fibroblast growth factor.confidentQ26614

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0018108 [BP]peptidyl-tyrosine phosphorylationprobableGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0018212, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0005887 [CC]integral to plasma membraneprobableGO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224
GO:0046777 [BP]protein autophosphorylationprobableGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0030855 [BP]epithelial cell differentiationprobableGO:0032502, GO:0060429, GO:0048869, GO:0030154, GO:0009888, GO:0044763, GO:0008150, GO:0009987, GO:0044699, GO:0048856
GO:0005007 [MF]fibroblast growth factor-activated receptor activityprobableGO:0038023, GO:0003824, GO:0016773, GO:0016772, GO:0016301, GO:0004714, GO:0060089, GO:0004888, GO:0016740, GO:0003674, GO:0004713, GO:0004871, GO:0004672, GO:0019199, GO:0004872
GO:0051129 [BP]negative regulation of cellular component organizationprobableGO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0048523, GO:0048519, GO:0051128, GO:0050789, GO:0044699
GO:0001657 [BP]ureteric bud developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0001655, GO:0048731, GO:0035295, GO:0072001, GO:0007275, GO:0044699
GO:0019216 [BP]regulation of lipid metabolic processprobableGO:0008150, GO:0065007, GO:0080090, GO:0019222, GO:0050789
GO:0031398 [BP]positive regulation of protein ubiquitinationprobableGO:0032268, GO:0009893, GO:0080090, GO:0060255, GO:0051246, GO:0031325, GO:0031401, GO:0031323, GO:0051247, GO:0050794, GO:0008150, GO:0048518, GO:0032270, GO:0031399, GO:0031396, GO:0065007, GO:0019222, GO:0010604, GO:0050789, GO:0048522
GO:0007507 [BP]heart developmentprobableGO:0032502, GO:0048513, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0005938 [CC]cell cortexprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0071944, GO:0044424
GO:0060045 [BP]positive regulation of cardiac muscle cell proliferationprobableGO:0042127, GO:0048638, GO:0048634, GO:0060043, GO:0050789, GO:0040008, GO:0046620, GO:0065007, GO:0048518, GO:0008284, GO:0016202, GO:0060420, GO:0050793, GO:0055024, GO:1901861, GO:0055021, GO:0008150, GO:0051239, GO:0050794, GO:0051094, GO:2000026, GO:0051240, GO:0048522
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0060445 [BP]branching involved in salivary gland morphogenesisprobableGO:0001763, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0007435, GO:0007431, GO:0048513, GO:0048729, GO:0022612, GO:0032502, GO:0032501, GO:0061138, GO:0060429, GO:0009888, GO:0044767, GO:0035272, GO:0008150, GO:0044707, GO:0048856, GO:0048731, GO:0048732
GO:0048610 [BP]cellular process involved in reproductionprobableGO:0009987, GO:0008150, GO:0000003
GO:0008286 [BP]insulin receptor signaling pathwayprobableGO:0042221, GO:0007169, GO:0070887, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0032869, GO:0032868, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0071375, GO:1901698, GO:0071417, GO:0071310, GO:0065007, GO:0071495, GO:0044700, GO:0009987, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0043434, GO:0010033, GO:1901700, GO:1901701, GO:0009725, GO:0010243, GO:1901699, GO:1901652, GO:1901653, GO:0008150, GO:0050896
GO:0045211 [CC]postsynaptic membraneprobableGO:0097060, GO:0044456, GO:0016020, GO:0005575, GO:0045202
GO:0007409 [BP]axonogenesisprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048812, GO:0008150
GO:0000165 [BP]MAPK cascadeprobableGO:0044700, GO:0051716, GO:0007243, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0050789, GO:0044699
GO:0001759 [BP]organ inductionprobableGO:0022603, GO:0030154, GO:0023052, GO:0050789, GO:0044699, GO:0003156, GO:0048869, GO:0051240, GO:0065007, GO:0048518, GO:0032502, GO:0031128, GO:0050793, GO:0009987, GO:0044763, GO:0051239, GO:0007267, GO:0007154, GO:0044700, GO:0045165, GO:0051094, GO:0045168, GO:2000026, GO:2000027, GO:0008150
GO:0035607 [BP]fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex developmentprobableGO:0071495, GO:0070887, GO:0021761, GO:0070848, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0007169, GO:0008543, GO:0007275, GO:0044699, GO:0021769, GO:0009719, GO:0051716, GO:0044344, GO:0050789, GO:0071310, GO:0048513, GO:0065007, GO:0007417, GO:0032502, GO:0032501, GO:0009987, GO:0050794, GO:0044767, GO:0042221, GO:0008150, GO:0007154, GO:0010033, GO:0044700, GO:0071363, GO:0007420, GO:0044707, GO:0050896, GO:0048856, GO:0044763, GO:0007399, GO:0030900, GO:0071774, GO:0048731
GO:0050877 [BP]neurological system processprobableGO:0032501, GO:0008150, GO:0044699, GO:0044707, GO:0003008
GO:0005911 [CC]cell-cell junctionprobableGO:0005575, GO:0030054
GO:0042592 [BP]homeostatic processprobableGO:0008150, GO:0065008, GO:0065007
GO:0010259 [BP]multicellular organismal agingprobableGO:0032502, GO:0032501, GO:0007568, GO:0044707, GO:0044767, GO:0008150, GO:0007275, GO:0044699
GO:0036342 [BP]post-anal tail morphogenesisprobableGO:0032502, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0043406 [BP]positive regulation of MAP kinase activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0023056, GO:0043405, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0043085, GO:0043408, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0032268, GO:0008150, GO:0042325, GO:0051174, GO:0042327, GO:0001932, GO:0031401, GO:0051338, GO:0045860, GO:0001934, GO:0048522
GO:0001948 [MF]glycoprotein bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0070374 [BP]positive regulation of ERK1 and ERK2 cascadeprobableGO:0023056, GO:0048584, GO:0010646, GO:0009966, GO:0009967, GO:0010740, GO:0048583, GO:0050794, GO:0043410, GO:0050789, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0048522, GO:0010627, GO:0070372, GO:0043408
GO:0005783 [CC]endoplasmic reticulumprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0090080 [BP]positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathwayprobableGO:0070887, GO:0048584, GO:0048583, GO:0070848, GO:0023056, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:0007169, GO:0010647, GO:0010646, GO:0010627, GO:0050789, GO:0044699, GO:0043408, GO:0009719, GO:0051716, GO:0009966, GO:0008543, GO:0044344, GO:0071310, GO:0065007, GO:0048518, GO:0010740, GO:0071495, GO:0007167, GO:0009987, GO:0050794, GO:0043410, GO:0042221, GO:0008150, GO:0007154, GO:0010033, GO:0044700, GO:0071363, GO:0050896, GO:0009967, GO:0071774, GO:0044763, GO:0048522
GO:0050731 [BP]positive regulation of peptidyl-tyrosine phosphorylationprobableGO:0019220, GO:0009893, GO:0019222, GO:0031325, GO:0031323, GO:0050789, GO:0080090, GO:0010604, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0045937, GO:0060255, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0050730, GO:0031401, GO:0001932, GO:0001934, GO:0048522
GO:0008544 [BP]epidermis developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045667 [BP]regulation of osteoblast differentiationprobableGO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0051239, GO:0008150, GO:0030278, GO:0050789
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0010470 [BP]regulation of gastrulationprobableGO:0045995, GO:0022603, GO:0050793, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0045597 [BP]positive regulation of cell differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0008201 [MF]heparin bindingprobableGO:0043168, GO:1901681, GO:0097367, GO:0043167, GO:0005539, GO:0003674, GO:0005488
GO:0021879 [BP]forebrain neuron differentiationprobableGO:0030154, GO:0044707, GO:0044699, GO:0007417, GO:0048869, GO:0007275, GO:0048513, GO:0021872, GO:0021953, GO:0032502, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0048731, GO:0022008, GO:0048699, GO:0007420, GO:0007399, GO:0048856, GO:0030900, GO:0044763
GO:0009898 [CC]internal side of plasma membraneprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0010863 [BP]positive regulation of phospholipase C activityprobableGO:0051336, GO:0060193, GO:0060191, GO:0019222, GO:0051345, GO:0050790, GO:0010518, GO:1900274, GO:0065007, GO:0043085, GO:0044093, GO:0008150, GO:0065009, GO:0050789, GO:0010517
GO:0007498 [BP]mesoderm developmentprobableGO:0032502, GO:0048856, GO:0008150, GO:0009888
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0072091 [BP]regulation of stem cell proliferationprobableGO:0042127, GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0045787 [BP]positive regulation of cell cycleprobableGO:0051726, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0019827 [BP]stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0042659 [BP]regulation of cell fate specificationprobableGO:0050793, GO:0010453, GO:0050794, GO:0045595, GO:0065007, GO:0008150, GO:0050789
GO:0003006 [BP]developmental process involved in reproductionprobableGO:0032502, GO:0022414, GO:0008150, GO:0000003
GO:0016477 [BP]cell migrationprobableGO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0051179, GO:0044699
GO:0009986 [CC]cell surfaceprobableGO:0005575, GO:0044464, GO:0005623
GO:0001525 [BP]angiogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0048646, GO:0048731, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0021847 [BP]ventricular zone neuroblast divisionprobableGO:0044707, GO:0030154, GO:0055057, GO:0048103, GO:0007405, GO:0044699, GO:0007417, GO:0048869, GO:0007275, GO:0048513, GO:0051301, GO:0061351, GO:0030900, GO:0021872, GO:0021873, GO:0032502, GO:0032501, GO:0008283, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0017145, GO:0048699, GO:0007420, GO:0007399, GO:0048856, GO:0021846, GO:0021869, GO:0008150, GO:0072089
GO:0042063 [BP]gliogenesisprobableGO:0032502, GO:0048856, GO:0044707, GO:0007399, GO:0009987, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0022008, GO:0007275, GO:0044699
GO:0017134 [MF]fibroblast growth factor bindingprobableGO:0003674, GO:0019838, GO:0005515, GO:0005488
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0042472 [BP]inner ear morphogenesisprobableGO:0042471, GO:0048598, GO:0048839, GO:0048562, GO:0044707, GO:0007423, GO:0048568, GO:0032501, GO:0048856, GO:0009887, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0043583, GO:0048731, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0060349 [BP]bone morphogenesisprobableGO:0048705, GO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0060348, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0033993 [BP]response to lipidprobableGO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0005764 [CC]lysosomeprobableGO:0005737, GO:0000323, GO:0043231, GO:0005773, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0002062 [BP]chondrocyte differentiationprobableGO:0032502, GO:0051216, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0009888, GO:0061448, GO:0008150, GO:0001501, GO:0048513, GO:0044763, GO:0048731, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0021954 [BP]central nervous system neuron developmentprobableGO:0048666, GO:0032502, GO:0048699, GO:0048856, GO:0030182, GO:0007399, GO:0008150, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0044767, GO:0009987, GO:0044763, GO:0044699, GO:0048731, GO:0022008, GO:0007275, GO:0021953, GO:0007417
GO:0030324 [BP]lung developmentprobableGO:0060541, GO:0032502, GO:0030323, GO:0044707, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0035295, GO:0007275, GO:0044699
GO:0048589 [BP]developmental growthprobableGO:0044767, GO:0032502, GO:0008150, GO:0040007, GO:0044699
GO:0048762 [BP]mesenchymal cell differentiationprobableGO:0032502, GO:0048863, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0009888, GO:0008150, GO:0048513, GO:0044763, GO:0048731, GO:0060485, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0060665 [BP]regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signalingprobableGO:0044700, GO:0044699, GO:0009987, GO:0051239, GO:0060638, GO:0050793, GO:0008150, GO:0022603, GO:0044763, GO:0023052, GO:0065007, GO:2000026, GO:2000027, GO:0060688, GO:0007267, GO:0007154, GO:0050789, GO:0060693
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0007389 [BP]pattern specification processprobableGO:0032502, GO:0032501, GO:0044707, GO:0008150, GO:0007275, GO:0044699
GO:0035108 [BP]limb morphogenesisprobableGO:0032502, GO:0048856, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048736
GO:0030424 [CC]axonprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0010975 [BP]regulation of neuron projection developmentprobableGO:0030154, GO:0051128, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0048731, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0051960, GO:2000026, GO:0007275, GO:0008150
GO:0031012 [CC]extracellular matrixprobableGO:0005575
GO:0031644 [BP]regulation of neurological system processprobableGO:0008150, GO:0065007, GO:0051239, GO:0044057, GO:0050789
GO:0060562 [BP]epithelial tube morphogenesisprobableGO:0032502, GO:0002009, GO:0048856, GO:0035239, GO:0044707, GO:0060429, GO:0009888, GO:0044767, GO:0032501, GO:0008150, GO:0048729, GO:0035295, GO:0009653, GO:0007275, GO:0044699

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 2PSQ, chain A
Confidence level:very confident
Coverage over the Query: 71-167,180-255
View the alignment between query and template
View the model in PyMOL
Template: 3VJO, chain A
Confidence level:probable
Coverage over the Query: 52-178,189-208
View the alignment between query and template
View the model in PyMOL